Kim, S., Dobi, E., Jary, M., Monnien, F., Curtit, E., NGuyen, T., . . . Borg, C. (2013). Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: Clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels. BioMed Central.
Style de citation ChicagoKim, Stefano, et al. Bifractionated CPT-11 With LV5FU2 Infusion (FOLFIRI-3) in Combination With Bevacizumab: Clinical Outcomes in First-line Metastatic Colorectal Cancers According to Plasma Angiopoietin-2 Levels. BioMed Central, 2013.
Style de citation MLAKim, Stefano, et al. Bifractionated CPT-11 With LV5FU2 Infusion (FOLFIRI-3) in Combination With Bevacizumab: Clinical Outcomes in First-line Metastatic Colorectal Cancers According to Plasma Angiopoietin-2 Levels. BioMed Central, 2013.